Arkham vs Bio Protocol — how do they compare? Arkham trades at Rp1,658 (market cap Rp374,35M, Rp1,03T 24h volume), while Bio Protocol trades at Rp437.34 (market cap Rp997,34M, Rp163,74M 24h volume). The key difference: Bio Protocol is far larger — about 2.7× Arkham's market cap, and Arkham's circulating supply is 225,1M / 1B ARKM (23%) versus 2,3B / 3,3B BIO (69%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Arkham for 51 Days and Bio Protocol for 18 Days on average.
| ARKM | BIO | |
|---|---|---|
Market Cap | Rp374,35M | Rp997,34M |
Volume (24h) | Rp1,03T | Rp163,74M |
Circulating Supply | 225,1M / 1B ARKM (23%) | 2,3B / 3,3B BIO (69%) |
Typical Hold Time | 51 Days | 18 Days |
Signals from Pluang's Aura AI — not financial advice
ARKM is trading at Rp1,669, showing a bearish technical outlook with moving averages signaling strong selling pressure and oscillators neutral. The current price is near the pivot point of Rp1,670, with immediate support at Rp1,641 and resistance at Rp1,698. No major protocol updates or ecosystem developments were noted recently, with a circulating supply of 225.1 million ARKM out of a 1 million max supply, indicating a 23% circulation rate.
The overall outlook is cautious due to bearish technical signals and limited fundamental catalysts. Key opportunities include potential rebounds from support levels, but risks involve high volatility, low liquidity, and regulatory uncertainties in the crypto space. Investors should monitor trading volume and on-chain activity for signs of recovery.
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
What Pluang investors did over the last 30 days
Arkham is a blockchain analysis platform that uses artificial intelligence to deanonymize the blockchain and on-chain data. Arkham’s platform can be used for various purposes, such as tracking stolen funds, identifying fraudsters, verifying counterparties, auditing transactions, investigating hacks, and more. Arkham claims its platform can help combat the proliferation of crypto crimes and scams by incentivizing on-chain research.
Read more on ARKM →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →